Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81

Warning: fopen(upload/ip_log/ip_log_2024-12.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83

Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84
The effect of mineral trioxide aggregate on the production of growth factors and cytokine by human periodontal ligament fibroblasts

The effect of mineral trioxide aggregate on the production of growth factors and cytokine by human periodontal ligament fibroblasts

Article information

Restor Dent Endod. 2007;32(3):191-197
Publication date (electronic) : 2007 May 31
doi : https://doi.org/10.5395/JKACD.2007.32.3.191
Department of Conservative Dentistry, College of Dentistry, Seoul National University, Korea.
Corresponding Author: WooCheol Lee. Department of Conservative Dentistry, College of Dentistry, Seoul National University and Dental Research Institute, 28 YunGun-Dong, ChongNo-Gu, Seoul, Korea, 110-749. Tel: 82-2-2072-1634, Fax: 82-2-2072-3859, jimin525@snu.ac.kr
Received 2007 February 23; Revised 2007 March 27; Accepted 2007 March 31.

Abstract

Mineral trioxide aggregate (MTA) would influence healing of periapical tissues by modulating the production of growth factors and cytokines from PDL fibroblasts, however, the studies are insufficient. Therefore, the purpose of this study was to monitor the expression of transforming growth factor-beta1 (TGF-β1), fibroblast growth factor-2 (FGF-2), and interleukin-6 (IL-6) from PDL fibroblasts in the presence of MTA. The human PDL fibroblasts were seeded onto the set MTA or IRM at a level of 1 × 105 cells per unit well, and further incubated for 6, 12, 24, and 48 hours. The levels of TGF-β1, FGF-2, and IL-6 from the supernatant were measured by enzyme-linked immunosorbent assay (ELISA). The data were analyzed using one-way ANOVA. The level of TGF-β1 was down-regulated when the cells were grown in the presence of MTA except at 6 hours. The levels of FGF-2 release were significantly suppressed when PDL fibroblasts were grown in the presence of MTA or IRM at all time intervals (p < 0.05). The expressions of IL-6 from MTA treated cells were comparable to those of untreated control cells throughout the observation periods. We presume that this material inhibits the stimulatory function of growth factors on granulation tissue formation and in turn, it promotes the healing process modulated by other bone-remodeling cells.

I. INTRODUCTION

During the periapical surgery, root-end cavity preparation and filling procedure following osteotomy and apical root resection should be performed for preventing recurrence of bacterial invasion and infection1). Various materials such as amalgam, zinc oxide eugenol (ZOE), IRM, and super EBA have been used for root-end filling in such situations2). Recently, mineral trioxide aggregate (MTA) became the most popular root-end filling material for its superior sealing ability3,4). MTA was also known to have an excellent biocompatibility. This material can induce the regeneration of periodontium - alveolar bone, periodontal ligament and cementum5-7). Furthermore, it is a material on which the cells can keep their healthy states, grow well and obtain firm attachment8-11). For these reasons, MTA is the material of choice when the root-end filling material is indicated.

Many biologic molecules get involved in wound healing process by several mechanisms. Growth factors and cytokines are mediator molecules that have important roles in tissue development and repair.12,13) Among the mediator molecules, transforming growth factor-beta1 (TGF-β1), fibroblast growth factor-2 (FGF-2), and cytokine interleukin-6 (IL-6) are one of the critical factors. TGF-β1 is known to be related to the mitogenesis of cells and the remodeling of extracellular matrix12,14) while FGF-2 has a potent angiogenic effect15). IL-6 is one of the well-known and plentiful inflammatory cytokines16).

In this regard, Koh et al.17) studied the cytokine production from osteoblastic cells in contact with MTA, and they found that MTA has an up-regulating effect on the expression of IL-1α, IL-1β, and IL-6 from osteoblasts.

Among the cells that constitute the periapical tissue, periodontal ligament (PDL) cells are one of the most abundant and produce many kinds of growth factors and cytokines18). Especially, PDL fibroblasts mainly exist in the periodontal ligaments that encapsulate the cementum of the root, affect the maintenance and regeneration of the periodontal tissue by regulating the turnover of collagen and alveolar bone remodeling, and contact directly with the sealing material when root-end filling procedure is performed19,20). In reference to this, it was reported that PDL fibroblasts can attach and grow well on MTA12).

However, studies regarding the relationship of MTA and growth factors or cytokines from PDL fibroblasts are insufficient. Therefore, the purpose of this study was to monitor the expression of transforming growth factor-beta1 (TGF-β1), fibroblast growth factor-2 (FGF-2), and interleukin-6 (IL-6) from PDL fibroblasts in the presence of MTA.

II. MATERIALS AND METHODS

Preparation of MTA and IRM

100 mg of MTA in white formulae (ProRoot MTA, Dentsply, Tulsa, OK, USA) was mixed with 0.3 mL of distilled water from the enclosed microdose ampoule. For comparison, intermediate restorative material (IRM) (Dentsply, Caulk) was prepared by mixing the same amounts of IRM powder as MTA with liquid according to the manufacturer's instructions. MTA and IRM samples were left to set for 7 days in the sterile well at 37 ℃ under 100 % humidity before cell culture.

Preparation of Cells

The human PDL fibroblasts were obtained from PDL of periodontaly healthy teeth. PDL tissue was cut out with a scalpel from the middle third part of the root surfaces of premolars extracted for orthodontic reasons. The tissue slices were incubated in Dulbecco's modified eagle's medium (DMEM: Life Technologies/GIBCO BRL. Gaithersberg, MD, USA) containing high glucose (4500 mg/L), 10000 U/L penicillin, 10000 µg/L streptomycin, 50µg/L Fungizone (Gemini Bio-Products Inc., Woodland, CA, USA), and 20% heat inactivated fetal bovine serum (FBS) at 37℃ under 5% CO2 and 100% humidity for 2 to 4 weeks. Through trypsinization, cells were removed and transferred into minimum essential medium alpha modification (α-MEM) containing 10% FBS and antibiotics, and continuously cultured. After 5 to 8 cell passages when sufficient cell proliferation was attained, these cells were trypsinized and seeded into the wells on which MTA or IRM had been set. The numbers of cells were 1 × 105 cells per unit well. Then the cells were incubated further for 6, 12, 24, and 48 hours in contact with MTA or IRM (n = 5 per group). The cells seeded and incubated on the wells without material were used as control group.

Enzyme-linked Immunosorbent Assay

Supernatant was collected from samples of each elapsed time in MTA, IRM, and control group and freezed for cold storage for subsequent analysis. After centrifuge (6000 rpm for 5 minutes), we measured the levels of TGF-β1, FGF-2, and IL-6 by enzyme-linked immunosorbent assay (ELISA). Quantikine ELISA kits (R&D systems, Minneapolis, MN, USA) were used for quantitative analysis and the reagents were added according to the manufacturer's instructions. The levels of color development of samples were measured at 450 nm by spectrophotometer (PowerwaveX340, Bio-Tek Instruments Inc., Winooski, VT, USA) and the concentrations of the growth factors and cytokine were determined from the corresponding values of optical density using standard curve. The data were analyzed using one-way ANOVA followed by Scheffe's post hoc test.

III. RESULTS

The levels of TGF-β1, FGF-2, and IL-6 production from PDL fibroblasts in all groups are demonstrated in Table 1. Figure 1 shows that the levels of TGF-β1 in all groups are relatively low. At 6 hours, the mean level of TGF-β1 in MTA group was 148.12 pg/mL, which was a little higher than 120.24 pg/mL in control group. Then the level of TGF-β1 in control group was increased and kept higher values than those in MTA group after 12 hours, and the differences were significant at 24 and 48 hours (p < 0.05). The production of TGF-β1 showed a tendency to increase with time in control group, and kept relatively constant level in MTA group. The expressions of TGF-β1 in IRM group were significantly suppressed and hardly detectable at all time points checked (p < 0.05).

Table 1

The mean values of TGF-β1, FGF-2 and IL-6 level

Figure 1

The levels of TGF-β1 expression.

The data of FGF-2 are expressed in Figure 2. The levels of FGF-2 production at 6 hours were 260.92 pg/mL in MTA group, 413.27 pg/mL in IRM group and 522.51 pg/mL in control group, with the highest value in control group and the lowest in MTA group. At 12 hours, the levels of FGF-2 in MTA and IRM group were decreased to 160.47 pg/mL and 107.27 pg/mL respectively, and kept declining with time thereafter. The levels in MTA group kept higher values than those in IRM group after 12 hours, but the differences were insignificant at 24 and 48 hours. The levels of FGF-2 in both experimental groups were significantly lower than that in control group at all time points observed (p < 0.05).

Figure 2

The levels of FGF-2 expression.

The graph in Figure 3 describes the levels of IL-6. The concentrations of IL-6 in MTA group were comparable to those in control group at all time points checked. No obvious variation with time was observed. The expressions of IL-6 in IRM group showed significantly decreased levels compared to those in two other groups throughout the experiment (p < 0.05).

Figure 3

The levels of IL-6 expression.

IV. DISCUSSION

The dentoalveolar healing mechanism after periradicular surgery is not fully revealed. After the resection of the apical portion of the root and the placement of root-end filling material, undifferentiated mesenchymal cells, fibroblasts, and fibroblast-like cells egress from the bone and periodontal ligament and these cells surround the root end to begin the healing process21,22). When it was used as a root-end filling material, fibrous connective tissue and thin layer of hard tissue formed in direct contact to MTA7,23). It is due to its low cytotoxicity against human PDL fibroblast, and for this reason, it is recommended to use of MTA in the root-end environment24). In this regard, we hypothesized that new root-end filling material MTA would influence the healing of tissues by modulating the production of growth factors and cytokines from PDL fibroblasts. Growth factors are known to be the essential molecules that act in the host defense and tissue regeneration25). Extensive wound healing studies in relation to growth factors demonstrated that TGF-β1 and FGF can promote tissue repair26). These mediators regulate hard and soft tissue healing mechanism by inducing recruitment, proliferation and differentiation of specific cells. It was reported that TGF-β1 stimulates the proliferation and differentiation of osteoblasts and induces bone formation27,28), however, its effects on bone healing appear inconsistent. Regarding the soft tissue healing, Okuda et al.29) demonstrated that this growth factor stimulated the biosynthesis of extracellular matrix components such as type I collagen, proteoglycan, glycosaminoglycan, and fibronectin. TGF-β1 also appears to inhibit the formation of extracellular matrix degrading protease and as a result it enhances the formation of granulation tissue. Takayama et al.30) have reported that FGF-2 influenced extracellular matrix formation by accelerating human endothelial cell migration and proliferation. It is also reported that FGF-2 potently stimulates angiogenesis which is critical for granulation tissue formation15). Our result suggests that MTA plays an important role in the process of periapical tissue healing by suppression of granulation tissue formation ability of these growth factors produced from PDL fibroblast. The similar molecules related to the tissue repair are called cytokines. Some authors do not discriminate cytokines from growth factors and consider them as the same category14). Main functions of cytokines are the recruitment and activation of immune and inflammatory cells. They activate the defensive mechanisms of host and prepare the basis for tissue regeneration. The cytokine IL-6 is an essential factor in protective response to injury and bone remodeling in wound healing31). From our result that there was no difference in expression of cytokine IL-6 in the presence of MTA compared to control indicates that bone remodeling mediated by IL-6 is undisturbed during periapical tissue healing process when PDL fibroblasts are grown in contact with MTA. This is in agreement with recent study showing that IL-6 was not produced by mouse fibroblast and macrophage cells cultured on MTA32). In the present experiment, positive control IRM was also shown to suppress growth factor expression. Therefore, it seems that there is no difference between MTA and IRM in their ability of modulating growth factor production from the PDL fibroblasts. However, IRM inhibited not only growth factors but also cytokine expressions from the cells. Koh et al.33) reported same result that cytokines such as IL-1α, IL-1β, and IL-6 were not produced from the osteoblast in the presence of IRM. It is thought that the toxicity of IRM totally suppressed the biologic function of cells and this phenomenon is mainly due to the well-known cytotoxic effect of this material. This result supports the use of MTA for the root-end filling material. The ideal goal of priradicular surgery is the complete healing of periapical tissue. We presume that root-end filling material MTA inhibits the stimulatory function of growth factors TGF-β1, FGF-2 on granulation tissue formation and in turn, it promotes the healing process modulated by other bone-remodeling cells. However, the effect of these growth factors in the presence of MTA on each type of cell population in the periapical tissue that is involved in tissue repair has not been fully clarified yet. It is hoped that the result of this study will provide valuable information for the better understanding of possible role of MTA as a root-end filling material in periapical tissue regeneration.

V. CONCLUSION

  1. MTA significantly suppressed the productions of TGF-β1 from PDL fibroblasts compared to control group at 24 and 48 hours (p < 0.05).

  2. MTA significantly down-regulated the expressions of FGF-2 at all time points checked (p < 0.05).

  3. MTA showed little effect on the expressions of IL-6 throughout the experiment (p > 0.05).

Notes

This study was supported by grant #04-2004-011-0 from Seoul National University Dental Hospital.

References

1. Gutmann JL, Harrison JW. Surgical endodontics 1994. St. Louis, MO: IEA Inc.;
2. Dorn SO, Gartner AH. Retrograde filling materials : a retrospective success-failure study of amalgam, EBA, and IRM. J Endod 1990. 16391–393.
3. Torabinejad M, Watson TF, Pitt Ford TR. Sealing ability of a mineral trioxide aggregate when used as a root end filling material. J Endod 1993. 19591–595.
4. Tang HM, Torabinejad M, Kettering JD. Leakage evaluation of root end filling materials using endotoxin. J Endod 2002. 285–7.
5. Torabinejad M, Pitt Ford TR, McKendry DJ, Abedi HR, Miller DA, Kariyawasam SP. Histologic assessment of mineral trioxide aggregate as a root-end filling in monkeys. J Endod 1997. 23225–228.
6. Torabinejad M, Ford TR, Abedi HR, Kariyawasam SP, Tang HM. Tissue reaction to implanted root-end filling materials in the tibia and mandible of guinea pigs. J Endod 1998. 24468–471.
7. Economides N, Pantelidou O, Kokkas A, Tziafas D. Short-term periradicular tissue response to mineral trioxide aggregate (MTA) as root-end filling material. Int Endod J 2003. 3644–48.
8. Koh ET, McDonald F, Pitt Ford TR, Torabinejad M. Cellular response to Mineral Trioxide Aggregate. J Endod 1998. 24543–547.
9. Mitchell PJ, Pitt Ford TR, Torabinejad M, McDonald F. Osteoblast biocompatibility of mineral trioxide aggregate. Biomaterials 1999. 20167–173.
10. Balto HA. Attachment and morphological behavior of human periodontal ligament fibroblasts to mineral trioxide aggregate: a scanning electron microscope study. J Endod 2004. 3025–29.
11. Thomson TS, Berry JE, Somerman MJ, Kirkwood KL. Cementoblasts maintain expression of osteocalcin in the presence of mineral trioxide aggregate. J Endod 2003. 29407–412.
12. . The potential role of growth and differentiation factors in periodontal regeneration. J Periodontol 1996. 67545–553.
13. Oringer RJ. Biological mediators for periodontal and bone regeneration. Compend Contin Educ Dent 2002. 501–504. 506–510. 512 passim. quiz 518.
14. Centrella M, McCarthy TL, Canalis E. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 1987. 2622869–2874.
15. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998. 9248–266.
16. Lyngstadaas SP, Lundberg E, Ekdahl H, Andersson C, Gestrelius S. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol 2001. 28181–188.
17. Koh ET, Torabinejad M, Pitt Ford TR, Brady K, McDonald F. Mineral trioxide aggregate stimulates a biological response in human osteoblasts. J Biomed Mater Res 1997. 37432–439.
18. Boyko GA, Melcher AH, Brunette DM. Formation of new periodontal ligament by periodontal ligament cells implanted in vivo after culture in vitro. A preliminary study of transplanted roots in the dog. J Periodontal Res 1981. 1673–88.
19. Melcher AH. On the repair potential of periodontal tissue. J Periodontol 1976. 47256–260.
20. McCulloch CAG, Bordin S. Role of fibroblast subpopulations in periodontal physiology and pathology. J Periodont Res 1991. 26144–154.
21. Corcoran JF, Sieraski SM, Ellison RL. Osseous healing kinetics after picoectomy in monkeys. II. A quantitative histologic appraisal. J Endod 1985. 11269–274.
22. Harrison JW, Jurosky KA. Wound healing in the tissues of the periodontium following periradicular surgery. III. The osseous excisional wound. J Endod 1992. 1876–81.
23. Regan JD, Gutmann JL, Witherspoon DE. Comparison of Diaket and MTA when used as root-end filling materials to support regeneration of the periradicular tissues. Int Endod J 2002. 35840–847.
24. Keiser K, Johnson CC, Tipton DA. Cytotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblast. J Endod 2000. 26288–291.
25. Graves DT, Cochran DL. Periodontal regeneration with polypeptide growth factors. Curr Opin Periodontol 1994. 1178–186.
26. Kissin EY, Lemaire R, Korn JH, Lafyatis R. Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation. Arthritis Rheum 2002. 463000–3009.
27. Piche JE, Graves DT. Study of the growth factor requirements of human bone-derived cells: a comparison with human fibroblasts. Bone 1989. 10131–138.
28. Chenu C, Pfeilschifter J, Mundy GR, Roodman GD. Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci 1988. 855683–5687.
29. Okuda K, Kawase T, Momose M, Murata M, Saito Y, Suzuki H, Wolff LF, Yoshie H. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol 2003. 74849–857.
30. Takayama S, Murakami S, Miki Y, Ikezawa K, Tasaka S, Terashima A, Asano T, Okada H. Effects of basic fibroblast growth factor on human periodontal ligament cells. J Periodontal Res 1997. 32667–675.
31. Ishimi Y, Miyaura C, Jin CH, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990. 1453297–3303.
32. Haglund R, He J, Jarvis J, Safavi KE, Spangberg LSW, Zhu Q. Effects of root-end filling materials on fibroblasts and macrophages in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003. 95739–745.
33. Koh ET, McDonald F, Pitt Ford TR, Torabinejad M. Cellular response to mineral trioxide aggregate. J Endod 1998. 24543–547.

Article information Continued

Figure 1

The levels of TGF-β1 expression.

Figure 2

The levels of FGF-2 expression.

Figure 3

The levels of IL-6 expression.

Table 1

The mean values of TGF-β1, FGF-2 and IL-6 level

Table 1

Concentration (pg/mL)

Standard deviations are in parenthesis.